BIOATLA, INC. Earnings Per Share, Basic and Diluted
BIOATLA, INC. (BCAB) reported Earnings Per Share, Basic and Diluted of -$0.65 per share for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-05.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-05-05
- BIOATLA, INC. earnings per share, basic and diluted for the quarter ending 2022-03-31 was -$0.65.
- BIOATLA, INC. earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$0.68.
- BIOATLA, INC. earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$0.90.
- BIOATLA, INC. earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$0.56.
- BIOATLA, INC. earnings per share, basic and diluted for fiscal 2021 was -$2.76.
- BIOATLA, INC. earnings per share, basic and diluted for fiscal 2020 was -$3.19.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2022-03-31 | -$0.65 10-Q · filed 2022-05-05 | |||
| 2021-12-31 | -$2.76 10-K · filed 2022-02-28 | |||
| 2021-09-30 | -$0.68 10-Q · filed 2021-11-15 | -$1.58 derived: net income ÷ weighted average shares · filed 2021-11-15 | -$2.13 10-Q · filed 2021-11-15 | |
| 2021-06-30 | -$0.90 10-Q · filed 2021-08-13 | -$1.46 10-Q · filed 2021-08-13 | ||
| 2021-03-31 | -$0.56 10-Q · filed 2022-05-05 | |||
| 2020-12-31 | -$3.19 10-K · filed 2022-02-28 | -$3.19 10-K · filed 2022-02-28 | ||
| 2020-09-30 | -$0.13 10-Q · filed 2021-11-15 | -$0.13 10-Q · filed 2021-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |